Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Neutropenia in children

소아기 호중구 감소증

  • Yoo, Eun Sun (Department of Pediatrics, Ewha Womans University School of Medicine, Mok-dong Hospital)
  • 유은선 (이화여자대학교 의학전문대학원 소아과학교실)
  • Received : 2009.05.18
  • Accepted : 2009.05.25
  • Published : 2009.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Neutropenia is defined as an absolute neutrophil count (ANC) of <$1,500/{\mu}L$, and the severity of neutropenia generally can be graded as mild ($1,000-1,500/{\mu}L$), moderate ($500-1,000/{\mu}L$), or severe (<500/$\mu{L}$). This stratification aids in predicting the risk of pyogenic infection because the susceptibility to life-threatening infections is significantly increased in patients with prolonged episodes of severe neutropenia. Especially cancer-related neutropenia carry significant mortality. Neutropenia can develop under various conditions such as decreased bone marrow production, the sequestering of neutrophils, and increased destruction of neutrophils in the peripheral blood. Neutropenia is classified according to the etiology as congenital or acquired, with the latter further defined according to the etiology or pathology. The clinical result is increased risk for infection, which is directly proportional to the severity and duration of the neutropenia. The typical workup of neutropenia starts with a 6-week period in which complete blood counts are measured twice weekly to document the persistence of the neutropenia and whether a cyclic pattern is present. When persistent neutropenia is diagnosed and no spontaneous recovery occurs within 3 months, a more extensive evaluation is advised. Treatment is usually unnecessary for most patients with severe neutropenia, as the majority of patients have a good prognosis. However, for patients who have severe and frequent infections, treatment with filgrastim may prevent infectious complications and improve quality of life.

Keywords

References

  1. Manroe B, Weinberg A, Rosenfeld C, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95:89-98 https://doi.org/10.1016/S0022-3476(79)80096-7
  2. Dinaner MC, Coates TD. Disorders of Phagocyte Function and Number. In: Hoffman F, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al, editors. Hematology: Basic Principles and Practice. 4th ed. Churchill Livingstone, 2005: 806-16
  3. James RM, Kinsey SE. The investigation and management of chronic neutropenia in children. Arch Dis Child 2006;91: 852-8 https://doi.org/10.1136/adc.2006.094706
  4. Boxer LA. Leukopenia. In: Kliegman RM, Jenson HB, Behrman RE, Stanton BF, editors. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders Co, 2007:909-15
  5. Segal GB, Halterman JS. Neutropenia in pediatric practice. Pediatr Rev 2008:29:12-23 https://doi.org/10.1542/pir.29-1-12
  6. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 2004:63-79
  7. Brown AE. Neutropenia, fever, and infection. Am J Med 1984;76:421-8 https://doi.org/10.1016/0002-9343(84)90661-2
  8. Schimpff SC. Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 1986;80:13-20
  9. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-59 https://doi.org/10.1086/514550
  10. Lalezari P, Khorshidi M, Petrosova M. Autoimmune neutropenia of infancy. J Pediatr 1986;109:764-9 https://doi.org/10.1016/S0022-3476(86)80690-4
  11. Logue GL, Shimm, DS. Autoimmune granulocytopenia. Annu Rev Med 1980;31:191-200 https://doi.org/10.1146/annurev.me.31.020180.001203
  12. Kyle R. Natural history of chronic idiopathic neutropenia. N Engl J Med 1980;302:908-9 https://doi.org/10.1056/NEJM198004173021608
  13. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, et al. Severe chronic neutropenia: treatment and follow- up of patients in the severe chronic neutropenia international registry. Am J Haematol 2003;72:82-93 https://doi.org/10.1002/ajh.10255
  14. James RM, Kinsey SE. The investigation and management of chronic neutropenia in children. Arch Dis Child 2006;91: 852-8 https://doi.org/10.1136/adc.2006.094706
  15. Hematology and oncology: Leukopenia and lymphocytopenia. In: Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. Whitehouse Station, NJ: Merck & Co,; 1999:847-1000
  16. Salama A, Schütz B, Kiefel V, Breithaupt H, Mueller-Eckhardt C. Immune mediated agranulocytosis related to drugs and their metabolites: Mode of sensitization and heterogeneity of antibodies. Br J Haematol 1989;72:127-32 https://doi.org/10.1111/j.1365-2141.1989.tb07672.x
  17. Murphy MF, Chapman JF, Metcalfe P, Waters AH. Antibiotic induced neutropenia. Lancet 1985;2:1306-7
  18. Andersohn F, Konzen C, Garbe E. Systematic review: Agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007;146:657-65
  19. Greenberg PL, Mara B, Steed S, Boxer L. The chronic idiopathic neutropenic syndrome: correlation of clinical features with in vitro parameters of granulocytopoiesis. Blood 1980; 55:915-21
  20. Strakebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol 2002;39:121-7 https://doi.org/10.1053/shem.2002.31918
  21. Dale DC, Bolyard AA, Aprilyan A. Cyclic neutropenia. Semin Hematol 2002;3:89-94
  22. Aprikyan AA, Dale DC. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol 2001;13:535-8 https://doi.org/10.1016/S0952-7915(00)00254-5
  23. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-73 https://doi.org/10.1086/513764
  24. Mendes AV, Sapolnik R, Mendonça N. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. Pediatr (Rio J) 2007:83;S54-63 https://doi.org/10.2223/JPED.1624
  25. Dale DC, Guerry D 4th, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine (Baltimore) 1979;58:128-44
  26. Boxer LA. Immune neutropenias: Clinical and biological implications. Am J Pediatr Hematol Oncol 1981;3:89-96
  27. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496-502
  28. Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006;107:4628- 35 https://doi.org/10.1182/blood-2005-11-4370

Cited by

  1. Clinical Characteristics of Severe Neutropenia in Children vol.24, pp.2, 2017, https://doi.org/10.15264/cpho.2017.24.2.81